Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Oct. 13: Vanderbilt University Medical Center Hosts Bone Marrow Disorders Symposium


 

Vanderbilt University Medical Center (VUMC) clinicians will host an educational symposium on bone marrow disorders, including bone marrow failure, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The free symposium for health care practitioners, sponsored by VUMC and the Aplastic Anemia and MDS International Foundation, will be held Friday, Oct. 13, 11:30 a.m. - 6 p.m., at the Omni Nashville Hotel, 250 5th Ave. South.

Bone marrow disease specialists from VUMC and other leading medical centers will provide the latest information on the diagnosis and management of bone marrow failure and myeloid malignancies based on current clinical practice guidelines and recent research studies. The expert faculty will provide insight into these rare disorders and offer recommendations for clinical practice.

Course director Michael Savona, M.D., associate professor of Medicine and director of Hematology Research at VUMC notes, "This is a unique opportunity for our local and referring medical communities to hear about exciting new drug approvals and treatment considerations specifically for myeloid cancers and bone marrow failure."

The educational sessions are appropriate for health care professionals working with patients with leukemia, MDS and other bone marrow failure, including hematologists, advance practice providers, oncologists, primary care physicians, pediatricians, pathologists, residents/fellows, physician assistants, nurses and nurse practitioners, and pharmacists. The activity is approved for continuing medical education (CME) credits.

VUMC faculty include Stephen Strickland Jr., M.D., M.S.C.I., assistant professor of Medicine and clinical director of Acute Leukemia, who will discuss newly approved therapy for AML; Michael Byrne, D.O., assistant professor of Medicine, who will review post-hematopoietic stem cell transplant relapse in AML; and Tamara Moyo, M.D., Ph.D., instructor of Medicine, who will discuss bone marrow failure and the role of stem cell transplant in patients with bone marrow failure.

They will be joined by Daniel Pollyea, M.D., M.S., clinical director of Leukemia Services at the University of Colorado School of Medicine, who will highlight new therapies including BCL-2 inhibitors; Mrinal Patnaik, M.B.B.S., assistant professor of Medicine at the Mayo Clinic, who will review strategies for overlaps syndromes (such as CMML) that have properties of both MDS and myeloproliferative neoplasms; and Amy DeZern, M.D., M.H.S., assistant professor of Medicine at Johns Hopkins School of Medicine, who will discuss the different types of myelodysplastic syndromes.

To register for the event, visit https://friendraising.donorpro.com/campaigns/390 or contact houk@aamds.org for more information.

 
Share:

Related Articles:


Recent Articles

Nashville's First Dedicated Clinic for Rape Exams Begins Taking Clients

Website includes interactive tool to help sexual assault victims determine if the SAFE Clinic is right for them

Read More

Practicing with Precision

Precision medicine holds great promise to tailor treatment in a manner that maximizes outcomes, yet a number of barriers exist that hinder the rapidly growing discipline's integration into daily practice.

Read More

Physician Spotlight: Brandon Downs, MD

Dr. Brandon Downs of Orthopaedic Specialists offers convenient, comprehensive services to patients who rely on his expertise in minimally invasive joint replacement and sports medicine.

Read More

Vanderbilt Bone & Joint Franklin Expands Staff, Adds Pediatric Services

Vanderbilt Bone & Joint Franklin greatly expands staff and adds pediatric services.

Read More

Regenerative Medicine in Orthopaedics

Regenerative medicine means less pain, more options for orthopaedic patients.

Read More

SJRI Opens Dickson Clinic

Southern Joint Replacement Institute opens Dickson clinic.

Read More

Health:Further Keynote Speakers Offer Energy And Insight

Although the annual Health:Further conference is best known for bringing innovative start-ups and investors together, the event also attracts healthcare and business organizations that have massive scale.

Read More

Industry Leaders Announce Innovative Orthopaedic Partnership

Saint Thomas Health, BlueCross BlueShield of Tennessee and Tennessee Orthopaedic Alliance recently announced a collaborative partnership for joint replacement.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: